Alembic Pharmaceuticals Confirms Compliance with SEBI Exemption Order for CRA Family Trust

Alembic Pharmaceuticals Ltd. has disclosed compliance with the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CRA Family Trust, ending 31st March, 2026. The disclosure refers to the SEBI Exemption Order no. WTM/GM/CFD/DCR1/35/2020-21 dated 30th September, 2020. M/s. D. K. Mehta & Co., Chartered Accountants have issued a certificate confirming compliance with the provisions of clause 6(ix) of the SEBI Exemption Order for the financial year ended 31st March, 2026. The company requests the stock exchanges to take the certificate on record.